#United States #Washington #Board of Directors #Evolent Health #Shawn Guertin

Evolent Health Welcomes New Board Nominee

Evolent Health, Inc. (NYSE: EVH) has recently announced the nomination of Shawn Guertin for election to its Board of Directors. This nomination is set to be presented at the annual meeting for shareholders on June 5, 2025, marking a key step in the company's ongoing efforts to refresh its board composition.

Shawn Guertin, who brings nearly four decades of experience in the insurance and healthcare sectors, has held significant leadership positions in several well-known companies. His most recent role was as the Executive Vice President and Chief Financial Officer at CVS Health Corporation, a position he served in from May 2021 to October 2023. This vast experience in management and financial oversight positions Guertin as a robust candidate to contribute to Evolent's mission of enhancing health outcomes for individuals with complex conditions.

The nomination process for Guertin was driven by Evolent's Nominating and Governance Committee, which has been focused on ensuring that the Board includes independent directors with diversified expertise. Guertin's extensive background in actuarial science, finance, and corporate management will not only aid Evolent in its strategic initiatives but also align with its emphasis on corporate governance best practices.

In a statement, Guertin expressed his excitement about the nomination, noting, “It is an honor to be nominated to the Board. I believe that Evolent offers a differentiated product for payers seeking to deliver top-quality clinical outcomes and healthcare value to members living with complex health conditions. I'm excited for the opportunity to help drive shareholder value.” His eagerness to contribute to Evolent's mission signifies a shared commitment towards improving healthcare delivery.

Evolent's Board Chair, Cheryl Scott, echoed the positive sentiment by stating, “Shawn brings an impressive track record of driving growth and profitability in the health care industry, and we are excited about the opportunity to have him join the Board.” As the company continues to evolve, Guertin's addition will mark the sixth new independent director to join the Board over the past four years, emphasizing Evolent's commitment to keeping its governance practices up-to-date and in line with industry standards.

Seth Blackley, Co-Founder and CEO of Evolent Health, highlighted Guertin's reputation as a respected leader among some of the most recognized healthcare brands in the U.S. He stated, “We look forward to benefiting from his guidance and his passion for our mission.”

Guertin's appointment will take the seat currently held by Diane Holder, who has opted not to seek re-election. Blackley expressed gratitude towards Holder for her contributions over the past 14 years, stating that her leadership has been instrumental in positioning Evolent as a frontrunner in value-based specialty care.

About Shawn Guertin

Shawn Guertin’s career reflects a commitment to excellence in the healthcare industry. In addition to his role at CVS Health, he previously served as Executive Vice President, CFO, and Chief Enterprise Risk Officer at Aetna, Inc., and held several critical leadership roles at Coventry Health Care. His educational background includes a B.A. in Mathematics from Boston University.

About Evolent Health

Evolent Health specializes in delivering improved health outcomes for individuals with complex healthcare needs through innovative solutions aimed at making healthcare more manageable and affordable. The company serves a wide range of leading payers and providers nationally and has garnered recognition as a top employer in the healthcare space. For more information on how Evolent is making a difference in healthcare delivery, visit Evolent Health's website.